Clinical drug trial centres in Andhra to be probed
June 25th, 2011 - 2:57 pm ICT by IANSNew Delhi, June 25 (IANS) After reports surfaced of a pharma company using poor women as guinea pigs for unauthorised drug trials in Andhra Pradesh, the Drugs Controller General of India (DCGI) has decided to probe all clinical trial centres in the state.
A Hyderabad-based drug research laboratory, Axis Clinicals Limited, allegedly administered trial drugs to a group of poor women from the Piduguralla town of Andhra Pradesh without taking their informed consent.
The Axis Clinical had conducted bio-equivalence studies on ‘exemestane’ tablets, an anti-cancer drug, from Jan 27 to Feb 15.
“It was alleged that the firm had conducted study by administering the anti-cancer drug to the poor women in Piduguralla town of Andhra Pradesh without securing their informed consent,” the statement said.
A probe by health officials revealed various irregularities with respect to subject recruitment process, informed consent process, independence of the ethics committee and its review and decision making process.
“After a thorough two-day investigations on June 20 and 21 at the bio-equivalence study centre of M/s Axis Clinicals Ltd at Hyderabad, approval was suspended,” an official health ministry statement said.
Following this, the DGCI has decided to investigate the working of all bio-availability and bio-equivalence study centres in Andhra Pradesh.
“Within a period of two months, we would ensure such clinical studies are performed strictly in accordance with the applicable regulatory provisions and prescribed guidelines,” the statement added.
- Two held for hiring women for drug trials - Jun 17, 2011
- Hyderabad lab checked for illegal clinical trials (Lead) - Jun 17, 2011
- Panel report on HPV vaccine trials slammed - May 09, 2011
- NHRC seeks response on unauthorised drug trial - Mar 19, 2012
- Chandigarh lab, northeast varsity work on cancer detector - Dec 01, 2011
- Panel to look into irregularities in drug trials - May 11, 2012
- GVK Bio gets approval from Turkey for bioequivalence studies - Mar 18, 2009
- NHRC slams health ministry for drug trial deaths - Aug 12, 2011
- Man undergoing drug test dies in Andhra Pradesh - Dec 07, 2008
- Rights panel to probe alleged drug trials on women - Jun 21, 2011
- Simple fingertip test may identify breast cancer patients at CTS risk - Dec 11, 2010
- Health ministry probing irregularities in drug trials (Lead) - May 10, 2012
- SC issues notice to government on clinical trials (Lead) - Feb 06, 2012
- Soft drink could boost effects of anti-cancer drug - Oct 14, 2010
- Lemon-lime soft drink could boost oral cancer treatment: Study - Nov 11, 2010
Tags: andhra pradesh, cancer drug, clinical trial, controller general, dcgi, dgci, equivalence, exemestane, exemestane tablets, guinea pigs, health ministry, health officials, informed consent, irregularities, ministry statement, pharma company, poor women, regulatory provisions, research laboratory, subject recruitment